a case of deep venous thrombosis in an hiv-infected patient despite therapeutic anticoagulation

Patients with human immunodeficiency virus (hiv) infection have an increased likelihood of venous thromboembolism (vte) owing to factors such as acquired protein c and s deficiency, antiphospholipid antibody syndrome, and heightened levels of pro-inflammatory cytokines. this case report highlights an exceptionally uncommon occurrence of deep venous thrombosis in an hiv-infected patient receiving a therapeutic dose of enoxaparin. this underscores the need for cautious consideration of the risk of vte in hiv-infected individuals, even with preventive or therapeutic anticoagulant treatment. further research is recommended to investigate hiv as a potential risk factor for prophylactic anticoagulation.